Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX29 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SNX29 mRNA | CTD | PMID:36331819 | 1,1-dichloroethene | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | vinylidene chloride results in decreased expression of SNX29 mRNA | CTD | PMID:26682919 | 1,2-dichloroethane | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of SNX29 mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | increases expression | ISO | Snx29 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SNX29 mRNA | CTD | PMID:22206623 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Snx29 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SNX29 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-hydroxypropanoic acid | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SNX29 mRNA | CTD | PMID:30851411 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of SNX29 gene | CTD | PMID:31601247 | aflatoxin B1 | affects expression | ISO | SNX29 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of SNX29 protein | CTD | PMID:20106945 | aflatoxin B1 | affects methylation | ISO | SNX29 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the methylation of SNX29 intron | CTD | PMID:30157460 | aflatoxin B1 | increases methylation | ISO | SNX29 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SNX29 gene | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of SNX29 mRNA | CTD | PMID:21641981 and PMID:32234424 | Aflatoxin B2 alpha | affects methylation | ISO | SNX29 (Homo sapiens) | 6480464 | aflatoxin B2 affects the methylation of SNX29 intron | CTD | PMID:30157460 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of SNX29 mRNA | CTD | PMID:30779732 | aristolochic acid A | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of SNX29 mRNA | CTD | PMID:33212167 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of SNX29 gene | CTD | PMID:28931070 and PMID:35440735 | benzo[a]pyrene | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of SNX29 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | increases methylation | ISO | SNX29 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SNX29 promoter | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | SNX29 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SNX29 3' UTR and Benzo(a)pyrene affects the methylation of SNX29 intron | CTD | PMID:27901495 and PMID:30157460 | benzo[a]pyrene | decreases methylation | ISO | SNX29 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of SNX29 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:26238291 | benzo[e]pyrene | increases methylation | ISO | SNX29 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of SNX29 intron | CTD | PMID:30157460 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SNX29 mRNA | CTD | PMID:19850644 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of SNX29 mRNA] | CTD | PMID:19850644 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SNX29 gene | CTD | PMID:28505145 | bisphenol A | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SNX29 gene | CTD | PMID:31601247 | bisphenol A | decreases methylation | ISO | SNX29 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of SNX29 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SNX29 mRNA | CTD | PMID:32145629 | bisphenol A | increases expression | ISO | SNX29 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SNX29 mRNA | CTD | PMID:29275510 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SNX29 mRNA | CTD | PMID:25181051 | butanal | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of SNX29 mRNA | CTD | PMID:26079696 | cadmium atom | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNX29 mRNA | CTD | PMID:37325564 | cadmium dichloride | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SNX29 mRNA | CTD | PMID:37325564 | carbon nanotube | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | carbon nanotube | increases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Nanotubes and Carbon results in increased expression of SNX29 mRNA | CTD | PMID:28673683 | chlorpyrifos | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of SNX29 mRNA | CTD | PMID:37019170 | chromium(6+) | affects expression | ISO | Snx29 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of SNX29 mRNA | CTD | PMID:28472532 | cisplatin | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of SNX29 mRNA | CTD | PMID:27392435 | cisplatin | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SNX29 mRNA | CTD | PMID:27392435 and PMID:27594783 | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SNX29 mRNA | CTD | PMID:26033743 | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of SNX29 mRNA | CTD | PMID:26033743 | coumarin | increases phosphorylation | ISO | SNX29 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of SNX29 protein | CTD | PMID:35688186 | coumestrol | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX29 mRNA | CTD | PMID:19167446 | dichloroacetic acid | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of SNX29 mRNA | CTD | PMID:28962523 | Enterolactone | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX29 mRNA | CTD | PMID:19167446 | epoxiconazole | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of SNX29 mRNA | CTD | PMID:35436446 | ethanol | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | Ethanol results in decreased expression of SNX29 mRNA | CTD | PMID:19167417 | ethanol | increases expression | ISO | Snx29 (Mus musculus) | 6480464 | Ethanol results in increased expression of SNX29 mRNA | CTD | PMID:30319688 | folic acid | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SNX29 mRNA | CTD | PMID:25629700 | FR900359 | increases phosphorylation | ISO | SNX29 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of SNX29 protein | CTD | PMID:37730182 | fulvestrant | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SNX29 gene and [bisphenol S co-treated with Fulvestrant] results in increased methylation of SNX29 gene | CTD | PMID:31601247 | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of SNX29 mRNA | CTD | PMID:25539665 | lipopolysaccharide | decreases expression | ISO | Snx29 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of SNX29 mRNA | CTD | PMID:25890327 | melphalan | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Melphalan results in decreased expression of SNX29 mRNA | CTD | PMID:22363485 | methapyrilene | increases methylation | ISO | SNX29 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of SNX29 intron | CTD | PMID:30157460 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of SNX29 gene | CTD | PMID:35440735 | methyl methanesulfonate | increases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of SNX29 mRNA | CTD | PMID:23649840 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of SNX29 gene | CTD | PMID:33148267 | O-methyleugenol | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of SNX29 mRNA | CTD | PMID:32234424 | ozone | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SNX29 mRNA | CTD | PMID:27106289 | paracetamol | increases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of SNX29 mRNA | CTD | PMID:29067470 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of SNX29 mRNA | CTD | PMID:33387578 | PCB138 | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Snx29 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SNX29 mRNA | CTD | PMID:36331819 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of SNX29 gene | CTD | PMID:33148267 | potassium chromate | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SNX29 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX29 mRNA | CTD | PMID:22079256 | rac-lactic acid | decreases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SNX29 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | ISO | SNX29 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SNX29 mRNA | CTD | PMID:23557933 | sodium arsenite | increases expression | ISO | SNX29 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SNX29 mRNA | CTD | PMID:22714537 and PMID:34032870 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of SNX29 mRNA | CTD | PMID:34492290 | trichostatin A | affects expression | ISO | SNX29 (Homo sapiens) | 6480464 | trichostatin A affects the expression of SNX29 mRNA | CTD | PMID:28542535 | trimellitic anhydride | increases expression | ISO | Snx29 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of SNX29 mRNA | CTD | PMID:19042947 | triptonide | increases expression | ISO | Snx29 (Mus musculus) | 6480464 | triptonide results in increased expression of SNX29 mRNA | CTD | PMID:33045310 | urethane | increases expression | ISO | SNX29 (Homo sapiens) | 6480464 | Urethane results in increased expression of SNX29 mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | Snx29 (Mus musculus) | 6480464 | Valproic Acid affects the expression of SNX29 mRNA | CTD | PMID:17963808 | |